Cargando…
Non‐genetic heterogeneity, altered cell fate and differentiation therapy
Altered capacity for self‐renewal and differentiation is a hallmark of cancer, and many tumors are composed of cells with a developmentally immature phenotype. Among the malignancies where processes that govern cell fate decisions have been studied most extensively is acute myeloid leukemia (AML), a...
Autores principales: | Lewis, Alexander C, Kats, Lev M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933953/ https://www.ncbi.nlm.nih.gov/pubmed/33555144 http://dx.doi.org/10.15252/emmm.202012670 |
Ejemplares similares
-
Dynamics and heterogeneity of a fate determinant during transition towards cell differentiation
por: Peláez, Nicolás, et al.
Publicado: (2015) -
Unraveling Heterogeneity in Epithelial Cell Fates of the Mammary Gland and Breast Cancer
por: Samocha, Alexandr, et al.
Publicado: (2019) -
Harnessing the Heterogeneity of T Cell Differentiation Fate to Fine-Tune Generation of Effector and Memory T Cells
por: Gong, Chang, et al.
Publicado: (2014) -
Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia
por: dos Santos, Guilherme Augusto, et al.
Publicado: (2013) -
Non-genetic heterogeneity caused by differential single-cell adhesion
por: Wang, Chun-Chao, et al.
Publicado: (2014)